I offer bioinformatics services for research, development, and clinical studies in the pharmaceutical and biotechnology sectors

Service Description

Innovative treatments stem from precisely documented experiments, not disorganized data.

• Is there a need to train an AI model for predicting drug-target interactions?
• Are clean data pipelines required for a phase II clinical trial?
• Is it challenging to convert laboratory results into insights ready for publication?

Ideal for: pharmaceutical research and development teams, emerging biotechnology companies, contract research organizations, hospital innovation departments, and researchers in dental and life science AI.

Core offerings:

• Defining research scope and formulating hypotheses
• Developing IRB-compliant protocols and statistical plans (GxP / ICH E6)
• Creating data engineering pipelines (ETL, de-identification for FHIR/OMOP)
• Developing models ranging from traditional statistics to advanced deep learning
• Tracking experiments (MLflow / W&B) and managing version-controlled datasets
• Designing interactive dashboards and visualizing results
• Drafting technical papers, concept summaries, and sections for grant applications
• Performing quality control and harmonization of laboratory, imaging, and omics data
• Ensuring compliance with regulations (HIPAA, GDPR, FDA 21 CFR Part 11)

Our advantages:

• Specialization in Life Sciences, Healthcare, and Artificial Intelligence
• Expertise with Electronic Health Records, omics data, medical imaging, and real-world evidence
• Providing reproducible analysis, transparent audit trails, and secure, auditable code transfer

For a tailored approach, please send project details to discuss possibilities.